NCT01698476View on ClinicalTrials.gov

Immune Reconstitution in Tuberculosis Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

390

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions
Pulmonary Tuberculosis (TB)
Interventions
DRUG

vitamin D (cholecalciferol) and PBA (sodium phenylbutyrate)

Dose of interventions: 5,000 IU of vitamin D (cholecalciferol tablets) once daily and 500 mg PBA (sodium phenylbutyrate tablets) twice daily for 16 weeks.

DRUG

Placebo tablets

Trial Locations (1)

Unknown

Black Lion Hospital (BLH), Addis Ababa University, Faculty of Medicine, Addis Ababa

All Listed Sponsors
collaborator

Addis Ababa University

OTHER

collaborator

Armauer Hansen Research Institute, Ethiopia

OTHER

lead

Karolinska Institutet

OTHER

NCT01698476 - Immune Reconstitution in Tuberculosis Disease | Biotech Hunter | Biotech Hunter